Home9966 • HKG
add
Alphamab Oncology
Previous close
$6.98
Day range
$6.40 - $7.00
Year range
$2.00 - $8.73
Market cap
6.31B HKD
Avg Volume
5.32M
P/E ratio
36.50
Dividend yield
-
Primary exchange
HKG
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 233.26M | 466.79% |
Operating expense | 124.80M | -3.61% |
Net income | 105.62M | 223.73% |
Net profit margin | 45.28 | 121.83% |
Earnings per share | — | — |
EBITDA | 107.66M | 227.77% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.57B | 11.67% |
Total assets | 2.24B | 4.90% |
Total liabilities | 409.87M | -11.86% |
Total equity | 1.83B | — |
Shares outstanding | 961.72M | — |
Price to book | 3.67 | — |
Return on assets | 10.45% | — |
Return on capital | 11.61% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 105.62M | 223.73% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2008
Website
Employees
420
